SHP Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.9K Sell
307
-169
-36% -$5.38K ﹤0.01% 896
2026
Q1
$12.6K Buy
476
+169
+55% +$4.95K ﹤0.01% 842
2025
Q4
$8.89K Buy
+307
New +$9.21K ﹤0.01% 863

Other funds holding ARKG

SHP Wealth Management's ARKG Position: Q2 2026 in Review

SHP Wealth Management reduced its ARK Genomic Revolution ETF (ARKG) stake by 36% in Q2 2026, selling an estimated $5.38K and leaving 307 shares worth $12.9K. The position accounts for ﹤0.01% of the portfolio, ranked #896.

SHP Wealth Management first reported a position in ARKG in Q4 2025 and has held it in 3 quarters since. 171 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • SHP Wealth Management held 307 shares of ARK Genomic Revolution ETF worth $12.9K as of Q2 2026.
  • SHP Wealth Management sold 169 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $5.38K.
  • ARK Genomic Revolution ETF made up ﹤0.01% of SHP Wealth Management's portfolio in Q2 2026, its #896 holding.
  • SHP Wealth Management first reported a position in ARK Genomic Revolution ETF in Q4 2025 and has held it in 3 quarters since.
  • 171 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on SHP Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.